ARIX Arix Bioscience

Hardman & Co Research: Q&A with Q&A with Dr Dorothea Hill on Arix Bioscience (ARIX)

Hardman & Co Research
Hardman & Co Research: Q&A with Q&A with Dr Dorothea Hill on Arix Bioscience (ARIX)

03-March-2020 / 07:30 GMT/BST

Hardman & Co Research: Q&A with Dr Dorothea Hill on Arix Bioscience

Arix Bioscience plc (ARIX) is the topic of discussion when Hardman & Co's analyst Dr Dorothea Hill caught up with DirectorsTalk for an exclusive interview.

Please click on the link below to listen to the interview:

If you are interested in meeting the company, you can register your interest by clicking on the above link

To contact us:

Hardman & Co
35 New Broad Street
London
EC2M 1NH

Follow us on Twitter @HardmanandCo

Contact:

Dorothea Hill

22

 


 

Hardman & Co Research can still be accessed for free after MiFID II. Please to read the statement.

About Hardman & Co: For the past 25 years Hardman has been producing specialist research designed to improve investors' understanding of companies, sectors, industries and investment securities. Our analysts are highly experienced in their sectors, and have often been highly rated by professional investors for their knowledge.  Our focus is to raise companies' profiles across the UK and abroad with outstanding research, investor engagement programmes and advisory services. Some of our notes have been commissioned by the company which is the subject of the note; this is clearly stated in the disclaimer where this is the case.

Hardman Research Ltd, trading as Hardman & Co, is an appointed representative of Capital Markets Strategy Ltd and is authorised and regulated by the Financial Conduct Authority; our FCA registration number is 600843. Hardman Research Ltd is registered at Companies House with number 8256259.

Our research is provided for the use of the professional investment community, market counterparties and sophisticated and high net worth investors as defined in the rules of the regulatory bodies.  It is not intended to be made available to unsophisticated retail investors. Anyone who is unsure of their categorisation should consult their professional advisors. This research is neither an offer, nor a solicitation, to buy or sell any security. Please read the note for the full disclaimer.

 


Dissemination of a CORPORATE NEWS, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.
End of Announcement - EQS News Service

987915  03-March-2020 

fncls.ssp?fn=show_t_gif&application_id=987915&application_name=news&site_id=research_pool
EN
03/03/2020

Underlying

ARIXArix Bioscience

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Arix Bioscience

ECK ECKOH
TYM Tertiary Minera... ... (+9)

Hybridan Small Cap Feast - 12 Feb 24

12th February 2024 @HybridanLLP Status of this Note and Disclaimer This document has been issued to you by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. This document has no regard for the specific investment obj...

ECK ECKOH
TYM TERTIARY MINERALS PLC
GOOD GOOD ENERGY GROUP
VAL VALIRX
DCTA DIRECTA PLUS
ARIX ARIX BIOSCIENCE
JNEO JOURNEO PLC
POLB POOLBEG PHARMA PLC
ECR ECR MINERALS PLC
02/12/24 February 12, 2024 1 EN
 PRESS RELEASE
Free
ARIX ARIX BIOSCIENCE

Scheme Effective

Arix Bioscience PLC (ARIX) Scheme Effective 12-Feb-2024 / 12:00 GMT/BST THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED IN IT ARE NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM, THE UNITED STATES OF AMERICA (INCLUDING ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED STATES AND THE DISTRICT OF COLUMBIA), AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION. FOR IMMEDIATE RELEASE Legal En...

February 12, 2024 1 EN
 PRESS RELEASE
Free
ARIX ARIX BIOSCIENCE

Suspension of Trading in Shares

Arix Bioscience PLC (ARIX) Suspension of Trading in Shares 12-Feb-2024 / 07:00 GMT/BST THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED IN IT ARE NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM, THE UNITED STATES OF AMERICA (INCLUDING ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED STATES AND THE DISTRICT OF COLUMBIA), AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION. FOR IMMEDIATE RE...

February 12, 2024 1 EN
 PRESS RELEASE
Free
ARIX ARIX BIOSCIENCE

Transaction Update

Arix Bioscience PLC (ARIX) Transaction Update 07-Feb-2024 / 11:30 GMT/BST THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED IN IT ARE NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM, THE UNITED STATES OF AMERICA (INCLUDING ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED STATES AND THE DISTRICT OF COLUMBIA), AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION. FOR IMMEDIATE RELEASE Legal ...

February 7, 2024 1 EN
 PRESS RELEASE
Free
ARIX ARIX BIOSCIENCE

Results of First General Meeting

Arix Bioscience PLC (ARIX) Results of First General Meeting 29-Jan-2024 / 12:15 GMT/BST THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED IN IT ARE NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM, THE UNITED STATES OF AMERICA (INCLUDING ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED STATES AND THE DISTRICT OF COLUMBIA), AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION. FOR IMMEDIATE R...

January 29, 2024 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch